Results 261 to 269 of about 16,645 (269)

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban

Thrombosis and Haemostasis, 2017
Sasha H Bakhru, Robert J Noveck
exaly  

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis

Hepatology Research, 2018
Yuko Nagaoki, Hiroshi Aikata, Takashi Nakahara   +2 more
exaly  

Edoxaban

Drugs, 2012
Alan J Camm, Henri Bounameaux
exaly  

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor

American Journal of Cardiovascular Drugs, 2013
Hamim Zahir, Robert J Noveck
exaly  

Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban

New England Journal of Medicine, 2014
Sasha H Bakhru, Robert J Noveck
exaly  

Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling

Journal of the American College of Cardiology, 2016
Robert P Giugliano, Eugene Braunwald, Harvey D White   +2 more
exaly  

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

Journal of Clinical Pharmacology, 2010
exaly  

Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa

Clinical Pharmacokinetics, 2015
exaly  

Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis

Thrombosis and Haemostasis, 2015
exaly